Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prothrombinex alone for warfarin reversal
ACTRN12607000567426Phase 4Recruiting
- Sponsor
- Frankston Hospital
- Start
- Jan 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of human prothrombin complex in coagulopathy (2 arms), sponsored by Frankston Hospital. Primary endpoint: Rapid reversal of warfarin. Started Jan 2008; status: recruiting.
02
Drugs
human prothrombin complex
03
Conditions
coagulopathy
Beyond the preview
Go deeper on ACTRN12607000567426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000567426.